Final EMA oracle [Regulatives / Guidelines]

posted by d_labes  – Berlin, Germany, 2010-02-01 16:20 (5993 d 02:12 ago) – Posting: # 4683
Views: 27,824

Dear ElMaestro,

Sorry, I had not the intention to put you in the shoes of defending this part of the Guidance. It was my outcry :crying: because I feared the worst you are definitely right in your interpretation.

That would mean for me a redesign of all the parts of my [image] programs dealing with crossover studies with more than two formulations! And a revision of all my internal effort to teach my folks the appropriate evaluation.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
351 visitors (0 registered, 351 guests [including 27 identified bots]).
Forum time: 19:33 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5